HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eliana M Barros Selected Research

Azaguanine

1/2019Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eliana M Barros Research Topics

Disease

4Neoplasms (Cancer)
03/2022 - 05/2014
3Genomic Instability
12/2017 - 05/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
03/2022 - 05/2014
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022
1AzaguanineIBA
01/2019
1Ligases (Synthetase)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Transfer RNA (tRNA)IBA
01/2019
1Estrogen ReceptorsIBA
05/2014
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
05/2014
1Estrogens (Estrogen)FDA Link
05/2014
1Proteins (Proteins, Gene)FDA Link
05/2014

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2017